ThermoGenesis Holdings Inc (THMO) gains 6.64% for July 21

Equities Staff  |

ThermoGenesis Holdings Inc (NASDAQ: THMO) shares gained 6.64%, or $0.15 per share, to close Wednesday at $2.41. After opening the day at $2.29, shares of ThermoGenesis fluctuated between $2.44 and $2.27. 419,058 shares traded hands an increase from their 30 day average of 321,665. Wednesday's activity brought ThermoGenesis’s market cap to $28,707,399.

ThermoGenesis is headquartered in Rancho Cordova, California..

About ThermoGenesis Holdings Inc

ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

Visit ThermoGenesis Holdings Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on ThermoGenesis Holdings Inc and to follow the company’s latest updates, you can visit the company’s profile page here: ThermoGenesis Holdings Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content